Ondine To Participate in Vancouver General Hospital Infection Control Project

MRSAid product by Ondine Biomedical

World Health Day is celebrated on the 7th of April every year to mark the establishment of the World Health Organization (WHO). Each year, the WHO selects a key health issue and encourages people from around the world to hold events and promote actions that will improve health. It is very fitting for Ondine then that this year’s World Health Day theme is “Combating Drug Resistance.” We have spent the last 70 years using and misusing antibiotics to treat and prevent common infectious diseases. Today, we have entered an era where bacteria have developed the ability to become resistant to most antibiotics, rendering them almost useless. It is therefore imperative that non-antibiotic solutions to fight infections are developed in order to preserve the next generation of effective medicine.

Today, we are very pleased to announce that Ondine Biomedical Inc is participating in an infection control Quality Improvement Project in one of Canada’s largest hospitals, Vancouver General Hospital (VGH). Over the course of this project, we will supply VGH with our MRSAidTM Photodisinfection System, an innovative and non-antibiotic therapy for nasal bacterial decolonization. It estimated that one in three people are colonized with Staphylococcus aureus and are at higher risk of self-infecting themselves when admitted into a hospital for surgery. Surgical site infections caused by Staphylococcus aureus and its antibiotic-resistant strain, MRSA, are responsible for additional patient recovery times and significant costs to the Canadian healthcare system.

MRSAidTM is a new therapeutic alternative for reducing the incidence of surgical site and other healthcare-associated infections (HAI’s). HAI’s are, a growing problem in Canadian hospitals, killing an estimated 8,000-12,000 patients every year. MRSAidTM will be used as part of a complete infection control bundle in Canadian hospitals. Advantages of MRSAidTM nasal decolonization are that the therapy is rapid, easy to administer, and does not generate resistant bacterial strains. Ondine is looking forward to working with VGH on this new, innovative & pioneering infection control project. To learn more about MRSAidTM, please visit www.mrsaid.com.

Related Posts Plugin for WordPress, Blogger...

Leave a Reply

Staypressed theme by Themocracy